Schedule 13G ownership disclosure

DIFFUSION PHARMACEUTICALS IN

Security class unavailable · CUSIP: 253748305

Event date: 2019-12-11

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
4.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-19-026687
Form type
SC 13G
Filer
CervoMed Inc.
CIK
CIK 1053691
Filed
Dec 20, 2019
Reporting period
Dec 11, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub